These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12440991)

  • 1. Intracellular ribozyme applications.
    Castanotto D; Li JR; Michienzi A; Langlois MA; Lee NS; Puymirat J; Rossi JJ
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1140-5. PubMed ID: 12440991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.
    Bramlage B; Alefelder S; Marschall P; Eckstein F
    Nucleic Acids Res; 1999 Aug; 27(15):3159-67. PubMed ID: 10454613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.
    Amarzguioui M; Brede G; Babaie E; Grotli M; Sproat B; Prydz H
    Nucleic Acids Res; 2000 Nov; 28(21):4113-24. PubMed ID: 11058107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA.
    Warashina M; Kuwabara T; Kato Y; Sano M; Taira K
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5572-7. PubMed ID: 11344300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA.
    Kearney P; Wright LA; Milliken S; Biggs JC
    Exp Hematol; 1995 Aug; 23(9):986-9. PubMed ID: 7543419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb.
    Jarvis TC; Wincott FE; Alby LJ; McSwiggen JA; Beigelman L; Gustofson J; DiRenzo A; Levy K; Arthur M; Matulic-Adamic J; Karpeisky A; Gonzalez C; Woolf TM; Usman N; Stinchcomb DT
    J Biol Chem; 1996 Nov; 271(46):29107-12. PubMed ID: 8910566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vivo activities of 5'-connected and 3'-connected cis-acting ribozymes: selection of intracellularly active ribozymes using the gene for dihydrofolate reductase (DHFR) as a selective marker in Escherichia coli.
    Hamada M; Fujita S; Kise H; Jigami Y; Taira K
    J Biochem; 1998 Apr; 123(4):684-92. PubMed ID: 9538262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribozymes: applications to functional analysis and gene discovery.
    Shiota M; Sano M; Miyagishi M; Taira K
    J Biochem; 2004 Aug; 136(2):133-47. PubMed ID: 15496583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA.
    Jarvis TC; Alby LJ; Beaudry AA; Wincott FE; Beigelman L; McSwiggen JA; Usman N; Stinchcomb DT
    RNA; 1996 May; 2(5):419-28. PubMed ID: 8665409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification and application of self-trimming hairpin ribozymes to targeting a transcribed RNA in vitro.
    Komatsu Y; Shirai M; Ohtsuka E
    J Biochem; 1998 Nov; 124(5):986-91. PubMed ID: 9792923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.